Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses.

[1]  C. Janeway,et al.  Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13. , 2013, Journal of immunology.

[2]  L. Zitvogel,et al.  Trial watch , 2012, Oncoimmunology.

[3]  J. Hubbell,et al.  Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. , 2012, Biomaterials.

[4]  A. Nagler,et al.  Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions , 2012, Clinical & developmental immunology.

[5]  M. Textor,et al.  Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  G. Dranoff,et al.  Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.

[7]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[8]  C. Olive.  Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants , 2012, Expert review of vaccines.

[9]  Koji Kajiwara,et al.  Dendritic cell vaccines. , 2012, Advances in experimental medicine and biology.

[10]  Y. Yoshioka,et al.  Induction of Endoplasmic Reticulum–Endosome Fusion for Antigen Cross-Presentation Induced by Poly (γ-Glutamic Acid) Nanoparticles , 2011, The Journal of Immunology.

[11]  A. Lavasanifar,et al.  Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. , 2011, Advanced drug delivery reviews.

[12]  Jun Jiao,et al.  Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response , 2011, Nature nanotechnology.

[13]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[14]  M. Textor,et al.  Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. , 2011, Biomaterials.

[15]  Ajay Kumar,et al.  Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy , 2011 .

[16]  S. Futaki,et al.  Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Azam Bolhassani,et al.  Improvement of different vaccine delivery systems for cancer therapy , 2011, Molecular Cancer.

[18]  C. Duvall,et al.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy. , 2010, Bioconjugate chemistry.

[19]  K. Berg,et al.  Photochemical internalization (PCI): a technology for drug delivery. , 2010, Methods in molecular biology.

[20]  David Pozo,et al.  Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[21]  R. Kane,et al.  Nanoparticle-mediated cytoplasmic delivery of proteins to target cellular machinery. , 2010, ACS nano.

[22]  C. Cluff.  Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. , 2010, Advances in experimental medicine and biology.

[23]  S. Futaki,et al.  Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  J. Heeney,et al.  Viruses as vaccine vectors for infectious diseases and cancer , 2010, Nature Reviews Microbiology.

[25]  L. Rajendran,et al.  Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.

[26]  H. Modjtahedi,et al.  Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. , 2009, Anti-cancer drugs.

[27]  A. Sorkin,et al.  Endocytosis and signalling: intertwining molecular networks , 2009, Nature Reviews Molecular Cell Biology.

[28]  Emanuele Cocucci,et al.  Distinct Dynamics of Endocytic Clathrin-Coated Pits and Coated Plaques , 2009, PLoS biology.

[29]  K. Berg,et al.  Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel , 2009, PloS one.

[30]  R. Bicknell,et al.  Anticancer strategies involving the vasculature , 2009, Nature Reviews Clinical Oncology.

[31]  P. Low,et al.  Folate-targeted therapeutic and imaging agents for cancer. , 2009, Current opinion in chemical biology.

[32]  A. Zhu,et al.  Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab , 2009, Expert review of anticancer therapy.

[33]  K. Lam,et al.  Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin. , 2009, Journal of medicinal chemistry.

[34]  Deborah Ferriola,et al.  Tyrosine kinase blockers: new hope for successful cancer therapy. , 2009, Anti-cancer agents in medicinal chemistry.

[35]  C. Cluff.  Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. , 2009, Advances in experimental medicine and biology.

[36]  H. Merkle,et al.  PEGylation as a tool for the biomedical engineering of surface modified microparticles. , 2008, Journal of pharmaceutical sciences.

[37]  M. Textor,et al.  Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[38]  J. Irache,et al.  Mannose-targeted systems for the delivery of therapeutics , 2008, Expert opinion on drug delivery.

[39]  V. Appay,et al.  CD8+ T cell efficacy in vaccination and disease , 2008, Nature Medicine.

[40]  Sanjay K. Jain,et al.  Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents. , 2008, Critical reviews in therapeutic drug carrier systems.

[41]  J. Irache,et al.  Mannose-targeted systems for the delivery of therapeutics. , 2008, Expert opinion on drug delivery.

[42]  M. Breunig,et al.  Polymers and nanoparticles: intelligent tools for intracellular targeting? , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  K. Berg,et al.  Photochemical internalization: a new tool for drug delivery. , 2007, Current pharmaceutical biotechnology.

[44]  Larry Norton,et al.  HER2 and response to paclitaxel in node-positive breast cancer. , 2007, The New England journal of medicine.

[45]  K. Schmader,et al.  Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults. , 2007, The American journal of geriatric pharmacotherapy.

[46]  D. Boturyn,et al.  Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. , 2007, Anti-cancer agents in medicinal chemistry.

[47]  P. Swaan,et al.  Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.

[48]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[49]  C. Hudis.  Trastuzumab--mechanism of action and use in clinical practice. , 2007, The New England journal of medicine.

[50]  B. Guy,et al.  The perfect mix: recent progress in adjuvant research , 2007, Nature Reviews Microbiology.

[51]  T. Kündig,et al.  A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles , 2007, Pharmaceutical Research.

[52]  S. Hamdy,et al.  “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells , 2007, Journal of immunotherapy.

[53]  Marcus Textor,et al.  Phagocytosis of poly (L-lysine)-graft-poly (ethylene glycol) coated microspheres by antigen presenting cells: Impact of grafting ratio and poly (ethylene glycol) chain length on cellular recognition , 2006, Biointerphases.

[54]  M. Carroll,et al.  Recombinant viral vectors: cancer vaccines. , 2006, Advanced drug delivery reviews.

[55]  B. Ludewig,et al.  Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma , 2006, Cancer Immunology, Immunotherapy.

[56]  B. Gander,et al.  Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. , 2006, Vaccine.

[57]  Federica Cavallo,et al.  Vaccines for tumour prevention , 2006, Nature Reviews Cancer.

[58]  Y. Tsutsumi,et al.  Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma. , 2006, Biological & pharmaceutical bulletin.

[59]  Linhong Li,et al.  Efficient Responses in a Murine Renal Tumor Model by Electroloading Dendritic Cells With Whole-Tumor Lysate , 2005, Journal of immunotherapy.

[60]  J. Lambert.  Drug-conjugated monoclonal antibodies for the treatment of cancer. , 2005, Current opinion in pharmacology.

[61]  Vladimir P Torchilin,et al.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. , 2005, Advanced drug delivery reviews.

[62]  H. Lyerly,et al.  Recent developments in therapeutic cancer vaccines , 2005, Nature Clinical Practice Oncology.

[63]  H. Merkle,et al.  DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. , 2005, Advanced drug delivery reviews.

[64]  Hans P. Merkle,et al.  Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages , 2003, Pharmaceutical Research.

[65]  Sun-Hee Kim,et al.  Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I–mediated antitumor immunity , 2004, Cancer Immunology, Immunotherapy.

[66]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[67]  T. Bieber,et al.  Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[68]  K. Berg,et al.  Evaluation of Different Photosensitizers for Use in Photochemical Gene Transfection¶ , 2001, Photochemistry and photobiology.

[69]  L. A. Alves,et al.  Pharmacologic properties of P(2Z)/P2X(7 )receptor characterized in murine dendritic cells: role on the induction of apoptosis. , 2000, Blood.

[70]  L. Leserman,et al.  Class I‐restricted presentation of exogenous antigen acquired by Fcγ receptor‐mediated endocytosis is regulated in dendritic cells , 2000, European journal of immunology.

[71]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[72]  F. Leyva-Cobián,et al.  Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis. , 1999, Blood.

[73]  H Anholt,et al.  Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.

[74]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[75]  J. Behr,et al.  Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. , 1994, Bioconjugate chemistry.

[76]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[77]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.